SS
Satya Srinivas Tangella
About Satya Srinivas Tangella
Data last updated:
Satya Srinivas Tangella is a Director at Elitecareoath Foundation (since 2023), Managing Director at Lumea Life Sciences Private Limited (since 2025) and Managing Director at Perlin Pharmaceuticals Private Limited (since 2019). The companies operate in Chemicals. The largest current company by reported revenue is Elitecareoath Foundation at ₹70,850 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Elitecareoath Foundation U88900AP2023NPL111469 | Director | 19 Jun 2023 | 2023 | ₹70,850 (FY 2025) | Active |
| Lumea Life Sciences Private Limited U21009AP2025PTC121866 | Managing Director | 28 Oct 2025 | 2025 | Active | |
| Perlin Pharmaceuticals Private Limited U24290TG2019PTC137238 | Managing Director | 29 Nov 2019 | 2019 | Active |
Board colleagues of Satya Srinivas Tangella
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naresh Potakamuri | 10163791 | Elitecareoath Foundation | Managing Director |
| Lakshmi Kumari Maguluri | 09702010 | Lumea Life Sciences Private Limited | Director |
| Saila Rani Adusumilli | 11348756 | Lumea Life Sciences Private Limited | Director |
| Girish Bathina | 09210971 | Perlin Pharmaceuticals Private Limited | Director |
| Lalitha Akondi | 08610335 | Perlin Pharmaceuticals Private Limited | Director |
| Suryaprabha Anasuri | 08610327 | Perlin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satya Srinivas Tangella
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satya Srinivas Tangella
Satya Srinivas Tangella currently holds 3 directorships: Elitecareoath Foundation (Director, since 19 Jun 2023, revenue ₹70,850 (FY 2025)); Lumea Life Sciences Private Limited (Managing Director, since 28 Oct 2025); Perlin Pharmaceuticals Private Limited (Managing Director, since 29 Nov 2019).
Satya Srinivas Tangella was first appointed on 29 Nov 2019 as Managing Director at Perlin Pharmaceuticals Private Limited. The most recent appointment on record is 28 Oct 2025 at Lumea Life Sciences Private Limited.
The current boards of Satya Srinivas Tangella's companies include Naresh Potakamuri (Elitecareoath Foundation), Lakshmi Kumari Maguluri (Lumea Life Sciences Private Limited), Saila Rani Adusumilli (Lumea Life Sciences Private Limited), Girish Bathina (Perlin Pharmaceuticals Private Limited), Lalitha Akondi (Perlin Pharmaceuticals Private Limited), Suryaprabha Anasuri (Perlin Pharmaceuticals Private Limited).